Why it matters
Primary care can catch risks an online intake may miss
Online peptide therapy can be convenient, but primary care often has the broader record: chronic conditions, prior labs, allergies, medication changes, specialist notes, pregnancy history, hospital or surgery plans, and local follow-up needs. Coordinating care reduces the chance that two clinicians make decisions from incomplete information.
- GLP-1 and GIP/GLP-1 medicines can affect stomach symptoms, hydration, glucose context, perioperative planning, and other medication decisions.
- Sermorelin, NAD+, glutathione, and GHK-Cu conversations should stay tied to realistic goals, route-specific risks, lab or skin context when relevant, and medication overlap.
- PT-141 or bremelanotide discussions should keep blood pressure, cardiovascular history, nausea, and medication context visible.
- Low-dose oral methylene blue requires extra interaction screening, especially serotonergic medicines and G6PD-related safety questions.